The approval of revakinagene taroretcel (Encelto; Neurotech) addresses a significant unmet need for patients with macular ...

Charles C. Wykoff, MD, PhD, Retinal Consultants of Texas, spoke to the current state of research on revakinagene taroretcel ...

Orsini, a leader in rare disease pharmacy solutions, has been selected by Neurotech Pharmaceuticals, Inc., as the exclusive ...

CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk ...

Results from the Phase III ZENITH trial show that Winrevair lowered the risk of all-cause death, lung transplantation, and ...

Orsini, a leader in rare disease pharmacy solutions, has been selected by Neurotech Pharmaceuticals, Inc., as the exclusive specialty pharmacy partner for ENCELTOtm (revakinagene taroretcel-lwey), an ...

Horbelt Intermediate School early because she was ill. Mirian was born with Ataxia-Telangiectasia (A-T), a disorder that impacts the nervous system and immune system. This past fall, she began using ...

Nampons™, the leading consumer brand for the treatment of nosebleeds, is expanding its retail availability with the launch of its popular Nampons™ and Nampons Kids™ at select Walmart stores nationwide ...

The most common adverse events with sotatercept were epistaxis and telangiectasia. The ongoing open-label SOTERIA extension study will continue to assess long-term safety. The study was funded by ...

Sotatercept, an activin signaling inhibitor, was associated with improved outcomes in patients with advanced pulmonary ...

Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) functional class (FC) 3 or 4 at ...